Trophic serves as a strategic partner for all aspects of communications for life science companies. We apply a deep understanding of both the science and business of drug development and the capital needed for success. Based on breadth and depth of experience, Trophic has become the go-to advisory for presenting corporate stories and scientific concepts. Current client portfolio ranges from biotech start-ups, listed biopharmas and small and large pharmaceutical companies.


Follow us on Twitter to stay tuned on biotech news and the inner workings of the Trophic team

Although we continue to #WFH, we can still celebrate some good news this month at Trophic. Today we would like to welcome our newest #TeamBean member, @SophiaHergenhan, as well as congratulate @jacobvinfo on his promotion to Account Manager. #Congrats #BiotechStrong #TrophicTeam

Working from home, like Bean, our VP #StressManagement & Nutrition? Bean's sharing a @HarvardBiz video with tips on how to #WFH, including advice on how to work alongside pets: If you have extra advice on how to make #HomeOffice a success, let us know!

Congratulations to @OncoOne on their EUR 13M #SeriesA and company launch. We look forward to following the Company's future developments in the #Oncology space.

Austrian startup @OncoOne has closed its first round of venture capital funding after raising €13M to investigate a new treatment target against solid #tumor cancers. #biotech #Austria

Load More...